Arbutus Biopharma Corp — Insider Transactions
Form 4 filings by directors, officers, and 10%+ shareholders
SEC rules require corporate insiders — including directors, executive officers, and any shareholder owning more than 10% of a company's shares — to report changes in their ownership within two business days of a transaction. These disclosures are filed as Form 4. Open-market purchases (code P) are generally considered the most meaningful signal, as insiders are spending their own money.
| Insider | Title | Type | Shares | Price | Value | Owns After | Date |
|---|---|---|---|---|---|---|---|
| Naftzger J. Christopher | General Counsel and CCO | Award / Grant | 54,300 | — | — | 140,544 | Feb 14, 2025 |
| McElhaugh Michael J. | Interim President & CEO | Award / Grant | 177,000 | — | — | 1,658,003 | Feb 14, 2025 |
| HASTINGS DAVID C | Chief Financial Officer | Award / Grant | 90,100 | — | — | 249,824 | Feb 14, 2025 |
| Sims Karen | Chief Medical Officer | Award / Grant | 49,300 | — | — | 155,494 | Feb 14, 2025 |
| HASTINGS DAVID C | Chief Financial Officer | Sale | 22,183 | $3.28 | $72,760 | 159,724 | Feb 4, 2025 |
| Sims Karen | Chief Medical Officer | Sale | 19,348 | $3.28 | $63,461 | 106,194 | Feb 4, 2025 |
| McElhaugh Michael J. | Interim President & CEO | Sale | 23,790 | $3.28 | $78,031 | 1,481,003 | Feb 4, 2025 |
| Naftzger J. Christopher | General Counsel and CCO | Sale | 11,333 | $3.28 | $37,172 | 86,244 | Feb 4, 2025 |
| MANCHESTER KEITH S | — | Option Exercise | 54,915 | $0.56 | $30,752 | 54,915 | Aug 14, 2024 |
| Naftzger J. Christopher | General Counsel and CCO | Award / Grant | 95,100 | — | — | 95,100 | Feb 1, 2024 |
| Sims Karen | Chief Medical Officer | Sale | 4,358 | $2.31 | $10,067 | 125,542 | Feb 1, 2024 |
| HASTINGS DAVID C | Chief Financial Officer | Sale | 9,593 | $2.31 | $22,160 | 181,907 | Feb 1, 2024 |
| Sofia Michael J. | Chief Scientific Officer | Sale | 9,982 | $2.31 | $23,058 | 1,485,121 | Feb 1, 2024 |
| McElhaugh Michael J. | Interim President & CEO | Sale | 10,164 | $2.31 | $23,479 | 1,504,793 | Feb 1, 2024 |
| McElhaugh Michael J. | Chief Business Officer | Award / Grant | 83,700 | — | — | 1,391,157 | Feb 1, 2023 |
| Sofia Michael J. | Chief Scientific Officer | Award / Grant | 82,200 | — | — | 1,385,603 | Feb 1, 2023 |
| HASTINGS DAVID C | Chief Financial Officer | Award / Grant | 79,000 | — | — | 79,000 | Feb 1, 2023 |
| Collier William H. | President and CEO | Award / Grant | 216,500 | — | — | 216,500 | Feb 1, 2023 |
| Howard Elizabeth | EVP, GC, Compliance | Award / Grant | 69,700 | — | — | 86,024 | Feb 1, 2023 |
| Sofia Michael J. | Chief Scientific Officer | Sale | 200,000 | $5.09 | $1,018,000 | 1,303,403 | Dec 1, 2021 |
| Roivant Sciences Ltd. | — | C | 22,833,922 | — | — | 38,847,462 | Oct 18, 2021 |
| McElhaugh Michael J. | Chief Business Officer | Sale | 20,000 | $5.00 | $100,000 | 1,307,457 | Feb 9, 2021 |
| McElhaugh Michael J. | Chief Business Officer | Sale | 30,000 | $5.00 | $150,000 | 1,337,457 | Dec 14, 2020 |
| McElhaugh Michael J. | Chief Business Officer | Sale | 20,000 | $5.01 | $100,200 | 1,367,457 | Jul 23, 2020 |
| Murray Mark J. | — | Option Exercise | 25,000 | $1.35 | $33,750 | 341,396 | Nov 28, 2018 |
| Sofia Michael J. | Chief Scientific Officer | Sale | 4,250 | $9.51 | $40,418 | 167,162 | Aug 13, 2018 |
| Sofia Michael J. | Chief Scientific Officer | Sale | 4,250 | $9.51 | $40,418 | 1,499,153 | Aug 13, 2018 |
| Sofia Michael J. | Chief Scientific Officer | Sale | 10,000 | $10.00 | $100,000 | 1,503,403 | Jul 11, 2018 |
| Sofia Michael J. | Chief Scientific Officer | Sale | 10,000 | $8.91 | $89,100 | 1,513,403 | Jul 6, 2018 |
| Sofia Michael J. | Chief Scientific Officer | Sale | 10,000 | $8.00 | $80,000 | 1,543,403 | Jul 5, 2018 |
| Murray Mark J. | President & CEO | Option Exercise | 27,007 | $0.35 | $9,452 | 316,396 | Apr 17, 2018 |
| Sofia Michael J. | Chief Scientific Officer | Sale | 10,000 | $8.00 | $80,000 | 1,553,403 | Oct 3, 2017 |
| Sofia Michael J. | Chief Scientific Officer | Sale | 10,000 | $3.75 | $37,500 | 191,412 | Aug 15, 2017 |
| Abrams Michael J. | Managing Director | Option Exercise | 14,178 | $0.35 | $4,962 | 42,097 | Aug 16, 2016 |
| Murray Mark J. | President & CEO | X | 5,000 | $2.57 | $12,850 | 289,389 | Jun 16, 2016 |
| Murray Mark J. | President & CEO | Option Exercise | 219,428 | $0.44 | $96,548 | 284,389 | Sep 11, 2015 |
| Abrams Michael J. | Managing Director | Option Exercise | 17,044 | $0.44 | $7,499 | 27,919 | Sep 11, 2015 |
| HENRIQUES RICHARD C JR | — | Purchase | 1,000 | $6.95 | $6,950 | 1,000 | Aug 24, 2015 |